F Forette

471 total citations
25 papers, 256 citations indexed

About

F Forette is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, F Forette has authored 25 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Psychiatry and Mental health and 2 papers in Pharmacology. Recurrent topics in F Forette's work include Dementia and Cognitive Impairment Research (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Pharmacology and Obesity Treatment (2 papers). F Forette is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Pharmacology and Obesity Treatment (2 papers). F Forette collaborates with scholars based in France, Netherlands and United States. F Forette's co-authors include Jan A. Staessen, Olivier Hanon, M Bellet, M. Guerret, P Berthaux, F. Latour, H. Lenoir, Marion Laurent, Hauw Jj and F. Piette and has published in prestigious journals such as British Journal of Clinical Pharmacology, Gerontology and Journal of Human Hypertension.

In The Last Decade

F Forette

25 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Forette France 8 132 95 64 45 33 25 256
Nicholas Christophidis Australia 8 218 1.7× 34 0.4× 63 1.0× 41 0.9× 99 3.0× 12 420
V. Hirth United States 5 104 0.8× 65 0.7× 110 1.7× 30 0.7× 24 0.7× 10 350
RJ Dobbs United Kingdom 9 93 0.7× 71 0.7× 52 0.8× 13 0.3× 39 1.2× 16 401
Ghassan Watfa France 11 125 0.9× 94 1.0× 107 1.7× 39 0.9× 8 0.2× 24 369
Szabolcs Szatmári Romania 13 47 0.4× 58 0.6× 45 0.7× 81 1.8× 21 0.6× 43 547
Yu‐Wan Yang Taiwan 14 39 0.3× 63 0.7× 70 1.1× 23 0.5× 36 1.1× 26 361
Ivan Walton United Kingdom 3 310 2.3× 273 2.9× 94 1.5× 127 2.8× 44 1.3× 5 533
Kimberly Ashby-Mitchell Australia 7 51 0.4× 145 1.5× 143 2.2× 29 0.6× 46 1.4× 9 413
Alexandra J. Bune Australia 12 207 1.6× 35 0.4× 272 4.3× 18 0.4× 53 1.6× 14 589

Countries citing papers authored by F Forette

Since Specialization
Citations

This map shows the geographic impact of F Forette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Forette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Forette more than expected).

Fields of papers citing papers by F Forette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Forette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Forette. The network helps show where F Forette may publish in the future.

Co-authorship network of co-authors of F Forette

This figure shows the co-authorship network connecting the top 25 collaborators of F Forette. A scholar is included among the top collaborators of F Forette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Forette. F Forette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanon, Olivier, et al.. (2005). Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).. PubMed. 9(2). 106–11. 34 indexed citations
2.
Hanon, Olivier, et al.. (2005). [Cognitive functions and hypertension].. PubMed. 98(2). 133–9. 5 indexed citations
3.
Komajda, Michel, F Forette, J.-F. Aupetit, et al.. (2004). Recommandations pour le diagnostic et la prise en charge de l'insuffisance cardiaque du sujet âgé.. Archives Des Maladies Du Coeur Et Des Vaisseaux. 97. 3 indexed citations
4.
Hanon, Olivier, et al.. (2004). Diuretics for cardiovascular prevention in the elderly. Journal of Human Hypertension. 18(S2). S15–S22. 4 indexed citations
5.
Forette, F, et al.. (2003). The prevention of dementia with antihypertensive treatment. New evidence from the systolic hypertension in europe (Syst-Eur) study. ACC Current Journal Review. 12(1). 32–33. 39 indexed citations
6.
Forette, F, et al.. (2000). Reduction of dementia by calcium-antagonist-based antihypertensive treatment. European Heart Journal Supplements. 2. 7 indexed citations
7.
Staessen, Jan A., et al.. (2000). Cognitief functieverlies en dementie bij bloeddrukverhoging; het effect van bloeddrukverlagende medicatie. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 144(42). 2033–2034. 1 indexed citations
8.
Seux, Marie‐Laure, F Forette, Jan A. Staessen, et al.. (1999). Treatment of isolated systolic hypertension and dementia prevention in older patients: Results of the Systolic Hypertension in Europe Trial (SYST-EUR) vascular dementia project. European Heart Journal Supplements. 1. 3 indexed citations
9.
Hanon, Olivier, Luiz Aparecido Bortolotto, Sylvie Legrain, et al.. (1999). [Antihypertensive treatment can normalize the geometry and the arterial function in the aged patient].. PubMed. 92(8). 1063–6. 4 indexed citations
10.
Thijs, Lutgarde, et al.. (1997). [Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study].. PubMed. 90(8). 1169–72. 1 indexed citations
11.
Forette, F, Michel Panisset, & François Boller. (1992). Clinical trials in cognitive impairment in the elderly. Aging Clinical and Experimental Research. 4(3). 239–250. 7 indexed citations
12.
Salom, Miguel G., et al.. (1989). [Efficacy and tolerability of cycletanine in aged patients with hypertension].. Therapies. 44(2). 101–6. 1 indexed citations
13.
Forette, F, et al.. (1987). [Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol].. PubMed. 36(2). 103–7. 4 indexed citations
14.
Forette, F, et al.. (1987). [Arterial hypertension in the elderly. Double-blind multicenter comparative study of labetalol and clonidine].. PubMed. 42(3). 277–83. 3 indexed citations
15.
Forette, F, et al.. (1985). Effect of nicardipine in elderly hypertensive patients.. British Journal of Clinical Pharmacology. 20(S1). 125S–129S. 46 indexed citations
16.
Forette, F, et al.. (1985). [Treatment of arterial hypertension in the aged subject with a converting enzyme inhibitor: enalapril].. PubMed. 14(44). 2237–41. 11 indexed citations
17.
Altamura, Carlo, et al.. (1981). Pharmacokinetics of amitriptyline in the elderly.. PubMed. 19(1). 1–5. 13 indexed citations
18.
Forette, F, et al.. (1980). [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].. PubMed. 9(48). 3685–8. 1 indexed citations
19.
Forette, F, et al.. (1979). [The treatment of hypertension in the elderly using a beta-blocker: acebutolol (author's transl)].. PubMed. 8(36). 2881–4. 3 indexed citations
20.
Amery, A, P Berthaux, W. H. Birkenhäger, et al.. (1977). Antihypertensive Therapy in Elderly Patients. Gerontology. 23(6). 426–437. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026